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T he prevalence of hypertension has continued to rise for the past 20 years. In the United States, only 1 of 3 patients with hypertension have their blood pressure (BP) controlled. Interventions that treat and prevent hypertension are urgently needed. 1 The pathogenesis of essential hypertension remains poorly understood. Genetic and behavioral factors do not fully explain the development of hypertension. Increasing evidence suggests that psychological stress leads to the development of hypertension in humans. 2, 3 For example, acute stress exposure triggers rapid increases in BP and heart rate (HR). 4, 5 Chronic stress and particularly the nonadaptive response to stress are associated with sustained elevation of BP. 6 Dysfunctions of central nervous system and neuroendocrine system are thought to contribute to the pathophysiological process of stressinduced hypertension, 4 but the critical central nervous system networks and the neurohormonal systems that regulate BP during psychological stress remain to be unraveled.
The ovarian hormone, estrogen, is long thought to prevent development of hypertension. Before menopause, BP has been typically lower in women than in age-matched men; after menopause, however, the incidence of hypertension in women increases dramatically. 7 In particular, psychological stress causes greater pressor responses in postmenopausal women than in premenopausal women, and this effect is blunted by 17β-estradiol replacement. 8 Multiple clinical trials have reported antihypertensive benefits of estrogen replacement in postmenopausal women. [9] [10] [11] [12] Unfortunately, higher risk of thromboembolism was also reported in postmenopausal women receiving estrogen replacement, 13 probably because of the procoagulation effects of estrogen.
14 Better understanding specific mechanisms for the antihypertensive effects of 17β-estradiol may facilitate developing new estrogen replacement therapies that only produce cardiovascular benefits with no or fewer side effects.
The amygdala, a neural complex near the temporal pole of the mammalian cerebral hemisphere, plays important roles in mediating the emotional and hormonal responses to stress. 15 Recent evidence indicates that the amygdala is involved in development of stress-induced pressor responses in humans. 16 In particular, neural activities in the medial amygdala (MeA), a subdivision of the amygdala, are positively correlated with stress-induced pressor responses in mice. 17, 18 Thus, increased MeA neural activities may mediate stress-induced pressor responses.
MeA neurons express abundant estrogen receptor-α (ERα), one of ERs. 19 Here, we tested a hypothesis that ERα expressed by MeA neurons is a key site where 17β-estradiol acts to prevent stress-induced pressor effects. To this end, we generated 2 mouse models with ERα deleted in the MeA. Using these tools, we examined the physiological functions of MeA ERα on stress-induced pressor responses. We also Abstract-Psychological stress contributes to the development of hypertension in humans. The ovarian hormone, estrogen, has been shown to prevent stress-induced pressor responses in females by unknown mechanisms. Here, we showed that the antihypertensive effects of estrogen during stress were blunted in female mice lacking estrogen receptor-α in the brain medial amygdala. Deletion of estrogen receptor-α in medial amygdala neurons also resulted in increased excitability of these neurons, associated with elevated ionotropic glutamate receptor expression. We further demonstrated that selective activation of medial amygdala neurons mimicked effects of stress to increase blood pressure in mice. Together, our results support a model where estrogen acts on estrogen receptor-α expressed by medial amygdala neurons to prevent stress-induced activation of these neurons, and therefore prevents pressor responses to stress. 
Methods

Mice
All mouse strains were backcrossed onto C57BL/6 background for >12 generations. SIM1-Cre transgene 21 was bred onto Esr1 f/f mice 22 to generate Esr1 f/f /SIM1-Cre and Esr1 f/f littermates, which were referred as SIM1-ERα-knockout (KO) and control mice, respectively. These mice were used for BP studies, quantitative polymerase chain reaction, and Western blotting, as described below. In parallel, Esr1 f/+ /SIM1-Cre mice were crossed to Esr1 f/+ /rosa26:green fluorescence protein (GFP) mice to generate Esr1 f/f /SIM1-Cre/rosa26GFP (SIM1-ERα-KO) mice and Esr1 +/+ /SIM1-Cre/rosa26GFP (control) mice. These mice were used for histology validation. In addition, the rosa26:tdTOMATO allele was crossed onto SIM1-Cre transgenic mice (control) or Esr1 f/f /SIM1-Cre mice (SIM1-ERα-KO), which were used for electrophysiological recordings. In addition, Esr1 f/+ mice were crossed to Esr1 f/+ to generate Esr1 f/f mice, which received AAV-Cre-GFP/AAV-GFP stereotaxic injections into the MeA. SIMCre transgenic mice were crossed to C57BL/6 mice to produce SIMCre transgenic mice, which were used for DREADD study.
All mice were weaned on chow diet (6.5% fat, no. 2920, Harlan) at 3 to 4 weeks of age and were grouped housed (2-5 mice per cage). For mice used in BP recording, they were singly housed after surgeries; other mice (eg, for electrophysiological studies) were grouped housed till study. All mice were housed in a 12-hour light and 12-hour dark cycle. Care of all animals and procedures were conformed to the Guide for Care and Use of Laboratory Animals of the US National Institutes of Health and approved by the Animal Subjects Committee of Baylor College of Medicine.
Colocalization of SIM1 and ERα
Female Esr1
f/f /SIM1-Cre/rosa26:GFP and SIM1-Cre/rosa26:GFP mice were perfused with 10% formalin. To avoid influence of estrous cycles on expression pattern, female mice were all perfused at diestrus. Briefly, mice for this study were subjected to daily vaginal smear followed by cytology evaluation. Exclusive leukocytes in the vaginal smear samples were used as a determinant for the stage of diestrus. Brain sections were cut at 25 μm (1:5 series) and the sections were incubated in the primary rabbit anti-ERα antibody (1:10 000; no. C1355, Millipore, Billerica, MA) overnight, followed by donkey antirabbit AlexaFluor594 (1:500; no. A21207, Invitrogen, Grand Island, NY) for 1.5 hours. Then, the sections were incubated in primary chicken anti-GFP antibody (1:5000; no. GFP-1020, Aves Laboratories, Inc, Tigard, OR) overnight, followed by the goat antichicken AlexaFluor 488 (1:250; no. A11039, Invitrogen) for 1.5 hours. The slides were cover slipped and images were analyzed using the Leica 5500 fluorescent microscope.
Effects of Subcutaneous 17β-Estradiol on StressInduced Pressor Responses
To examine the effects of estrogen, 12-week-old female control and SIM1-ERα-KO mice were anesthetized with inhaled isoflurane. As previously described, 23, 24 bilateral ovariectomy was performed, followed by subcutaneous implantations of pellets containing 17β-estradiol (0.5 μg/d lasting for 30 days, OVX+E) or empty pellets (OVX+V). These pellets were purchased from Innovative Research of America. Under the same anesthesia, the left carotid artery was isolated, and the catheter of the telemetry transmitter (TA11PA-C10, Data Sciences International, St. Paul, MN) was inserted into the vessel. The body of the transmitter was slipped in a subcutaneous pocket along the right flank. The mice were allowed to recover for 7 days and then followed by recording for BP and HR using DSI Physio Tel Receivers (Data Sciences International). On the recording day, BP and HR were recorded continuously for 2 phases: the acclimation phase (8 am-11 am) and the restraint phase (11 am -12 am). Twenty minutes before the restraint phase (10:40 AM), the experimenter entered the room and turned on the telemetry probe with a magnetic switch. At 11 AM, the experimenter re-entered the room to restrain mice with a mouse plastic restraining cone, which immobilized the mice. Importantly, mice were maintained at the normal position and were able to breathe normally; there were no pain or discomfort except that mice could not move. BP and HR data during the past 20 minutes during the acclimation phase were used as the baseline.
Because the stress-induced pressor responses may be influenced by different baseline BP/HR levels, we first performed pilot studies in a small cohort of wild-type OVX+V and OVX+E mice to compare their 24-hour baseline mean arterial pressure (MAP) and HR. We found that OVX+E mice showed significantly reduced MAP compared with OVX+V mice during the entire dark cycle and the early phase of light cycle; however, during 10 AM to 2 PM, there was no significant difference in MAP between the 2 groups ( Figure S1A , in the online-only Data Supplement). However, HR was not significantly different between OVX+V and OVX+E mice throughout the entire 24-hour period ( Figure S1B ). On the basis of these observations, we chose to perform the restraint stress during 11 AM to 12 PM, as described above.
Note that hypertension is often associated with obesity. 25 We chose to perform BP/HR recording 7 days after OVX+V/E treatment, because body weight is comparable within at this time point. 23 At the end of recordings, mice were euthanized. Fat pads were weighed to ensure comparable adiposity between the groups (data not shown). Uteruses were weighted to confirm successful 17β-estradiol depletion in OVX+V mice and sufficient 17β-estradiol supplement in OVX+E mice.
Deletion of ERα in the MeA
Female Esr1
f/f mice were anesthetized by isoflurane and received bilateral stereotaxic injections of AAV-Cre-GFP (AAV9.CMV.HI.GFPCre.WPRE.SV40, Penn Vector Core at University of Pennsylvania, Philadelphia, PA) into the MeA (200 nL/side), and these mice were referred as MeA-ERα-KO. Esr1 f/f mice that received AAV-GFP in the MeA were used as controls. The coordinates for the MeA were 1.7 mm posterior and 2.5 mm lateral to the Bregma, and 5 mm ventral to the dura. After the recovery from the stereotaxic surgeries (7 days), these mice received the OVX+E treatment and implantation of the telemetry transmitters, followed by recordings of BP and HR under the baseline condition and the restrained condition, as described above.
At the end of the experiment, all mice were perfused with 10% formalin. Brain sections were collected, and expression of GFP was checked in the MeA. Only those with expression of GFP exclusively in both MeA sides were included in data analyses. To further validate the deletion of ERα, some brain sections with accurate GFP expression were also subjected to ERα immunofluorescent staining, as described above.
DREADD Activation of MeA SIM1 Neurons
Female SIM1-Cre mice (at 14-16 weeks of age) were anesthetized by isoflurane and received bilateral stereotaxic injections of AAVhM3Dq-mCherry (AAV-hSyn-DIO-hM3D(Gq)-mCherry in AAV2, UNC Vector Core, Chapel Hill, NC) into the MeA (200 nL/side), followed by a second surgery to receive the implantation of the telemetry transmitters, as described above. After recovery, BP and HR were recorded continuously during 9 AM to 11 AM, with an intraperitoneal injection of saline or clozapin N-oxide (CNO; 3 mg/kg) at 10 AM.
Both saline and CNO were tested in the same mice at 2 different trials (at the same time of the day) with a 1-week interval; the order of the 2 injections was randomized to avoid any sequence effect.
At the end of experiment, all mice were perfused with 10% formalin. Brain sections were collected and subjected to mCherry immunohistochemistry, as described before. 26 Briefly, brain sections were first incubated in 0.3% H 2 O 2 in PBS for 30 minutes to abolish endogenous peroxidase activity. After several washes, sections were incubated overnight at room temperature with the primary rabbit Living Colors DsRed polyclonal antibody (1:1000, Clontech Laboratories, Inc, Mountain View, CA). After several washes, sections were incubated by guest on August 30, 2017 http://hyper.ahajournals.org/ Downloaded from with the biotinylated secondary antibody (1:1000, antirabbit, Jackson Immuno Research, West Grove, PA) for 1 hour. Sections were then washed and visualized by incubation with the VECTASTAIN ABC kit (Vector Laboratories, Burlingame, CA) according to the manufacture's instruction. Sections were washed and treated with diaminobenzidine (Sigma, St. Louis, MO) for 5 minutes, followed by dehydration in a graded ethanol series from 50% to 100% and a final wash in xylene. The slides were cover slipped and images were analyzed using the Leica 5500 microscope under the brightfield. Only those with mCherry immunoreactivity selectively in both MeA sides were included in data analyses.
To prove the concept that CNO does activate hM3Dq-mCherryexpressing MeA SIM1 neurons, some SIM1-Cre mice were used for electrophysiological recordings after the stereotaxic AAV-hM3Dq-mCherry injections, as described below.
Electrophysiology
Whole-cell patch-clamp recordings were performed on TOMATOlabeled SIM1 neurons in the acute MeA slices from SIM1-Cre/ rosa26:tdTOMATO mice and Esr1 f/f /SIM1-Cre/rosa26:tdTOMATO (SIM1-ERα-KO) mice. As we described before, 26,27 6-to 12-week-old female mice were deeply anesthetized with isoflurane and transcardially perfused with a modified ice-cold sucrose-based cutting solution (adjusted to pH 7.3) containing (in mmol/L) 10 NaCl, 25 NaHCO 3 , 195 sucrose, 5 glucose, 2.5 KCl, 1.25 NaH 2 PO 4 , 2 Na pyruvate, 0.5 CaCl 2 , 7 MgCl 2 bubbled continuously with 95% O 2 and 5% CO 2 . The mice were then decapitated, and the entire brain was removed and immediately submerged in ice-cold sucrose-based cutting solution. Coronal sections containing the MeA (250 μm) were cut with a Microm HM 650V vibratome (Thermo Scientific). The slices were recovered for 1 hour at 34°C in artificial cerebrospinal fluid (adjusted to pH7.3) containing (in mmol/L) 126 NaCl, 2.5 KCl, 2.4 CaCl 2 , 1.2 NaH 2 PO 4 , 1.2 MgCl 2 , 11.1 glucose, and 21.4 NaHCO 3 28 saturated with 95% O 2 and 5% CO 2 before recording.
Slices were transferred to the recording chamber and allowed to equilibrate for at least 10 minutes before recording. The slices were perfused at 34°C in oxygenated artificial cerebrospinal fluid at a flow rate of 1.8 to 2 mL/min. tdTOMATO-positive SIM1 neurons in MeA were visualized using epifluorescence and IR-DIC imaging on an upright microscope (Eclipse FN-1, Nikon) equipped with a moveable stage (MP-285, Sutter Instrument). Patch pipettes with resistances of 3 to 5 mol/LΩ were filled with intracellular solution (adjusted to pH 7.3) containing (in mmol/L) 128 K gluconate, 10 KCl, 10 HEPES, 0.1 EGTA, 2 MgCl 2 , 0.05 Na-GTP, 3 Mg-ATP, and 0.1 lucifer yellow dye. Recordings were made using a MultiClamp 700B amplifier (Axon Instrument), sampled using Digidata 1440A and analyzed offline with pClamp 10.3 software (Axon Instrument). Series resistance was monitored during the recording, and the values were generally <10 MΩ and were not compensated. The liquid junction potential was +12.5 mV and was corrected after the experiment. Data would be excluded if the series resistance increased >20% during the experiment or without overshoot for action potential.
Neural firing frequency and resting membrane potential were measured under the current-clamp mode. For the miniature excitatory postsynaptic current (mEPSC) recordings, the internal recording solution contained (in mmol/L): CsCH 3 SO 3 125, CsCl 10, NaCl 5, MgCl 2 2, EGTA 1, HEPES 10, (Mg)ATP 5, and (Na)GTP 0.3 (pH 7.3 with NaOH). mEPSC was measured in the voltage-clamp mode with a holding potential of −60 mV in the presence of 1 μmol/L tetrodotoxin 29 and 50 μmol/L bicuculline. 30 For the miniature inhibitory postsynaptic current recordings, patch electrodes were filled with a recording solution that contained (in mmol/L): 153.3 CsCl, 1.0 MgCl2, 5.0 EGTA, and 10.0 HEPES, pH of 7.20 with CsOH. 31 CsCl was included to block potassium currents. Mg-ATP (3 mmol/L) was added to the intracellular solution before recording. Glutamate receptor-mediated synaptic currents were blocked by 30 μmol/L D-AP-5 and 30 μmol/L CNQX in the external solution, along with 1 μmol/L tetrodotoxin in the external solution blocking action potentials. Neurons were voltage clamped at −70 mV during the recording. Slices were fixed with 4% formalin in PBS at 4°C overnight and then subjected to post hoc identification of the anatomic location of the recorded neurons within the MeA.
To validate that hM3Dq-mCherry-expressing MeA SIM1 neurons can be activated by CNO treatment, the MeA-containing brain slices were prepared from SIM1-Cre mice receiving stereotaxic AAV-hM3Dq-mCherry injections. Effects of CNO (10 μmol/L, bath perfusion 6 minutes) on the firing frequency and resting membrane potential were recorded in mCherry-labeled neurons under the current-clamp mode.
Real-Time Reverse Transcription-Polymerase Chain Reaction
Female SIM1-ERα-KO and control littermates were euthanized at diestrus, and the amygdala was quickly microdissected and stored at −80°C. Real-time reverse transcription-polymerase chain reaction was performed as described previously. 32 Primer sequences were listed in Table S1 .
Western Blot
Female SIM1-ERα-KO and control littermates were euthanized at diestrus, and the amygdala was quickly microdissected. Subsequently, the fresh whole amygdala tissue was homogenized in cell lysis buffer that was supplemented with protease inhibitors and phosphatase inhibitors. Then, cell lysates were combined with 1X Laemmli buffer, and boiled for 5 minutes. The precipitated proteins were separated by SDS-8% PAGE and the samples were transferred onto nitrocellulose membranes (BioRad Transfer equipment). Dry powder milk was dissolved into Tris-buffered saline and Tween 20 (50 mmol/L Tris-HCL, 150 mmol/L NaCl [pH 7.5], 0.1% Tween 20) to have a final 3% concentration and added to the nitrocellulose membranes for 1 hour. The membranes were washed in Tris-buffered saline and Tween 20 for 5 minutes 3×. The nitrocellulose membranes were incubated with antiglutamate receptor N subunit antibody (anti-GluN1; 1:1,000; Cat no. 4204, Cell Signaling Technology) overnight, followed by incubation with the antirabbit horseradish peroxidase-conjugated secondary antibody (1:10,000; Cat no. 7074, Cell Signaling Technology) for 1 hour at the room temperature. Similarly, as a loading control, the nitrocellulose membranes were incubated with mouse anti-β actin (1:5,000; Cat no. A3853, Sigma-Aldrich), followed by the antimouse horseradish peroxidase-conjugated secondary antibody (1:10,000; Cat no. 7076P2, Cell Signaling Technology). Western blots were visualized with Thermo Fisher Scientific SuperSignal West Pico Chemoluminescence substrate.
Serum Corticosterone
To measure stressed levels of corticosterone, mice were restrained for 15 minutes, and blood was collected from the tail vein; for the measurements of basal corticosterone, mice were rapidly decapitated at 9:00 AM and trunk blood was collected. Blood samples were processed to measure serum corticosterone using a corticosterone EIA kit (900-097, Assay Designs, Ann Arbor, MI).
Statistical Analyses
The data are presented as mean±SEM. Statistical analyses were performed using GraphPad Prism to evaluate normal distribution and variations within and among groups. Methods of statistical analyses were chosen based on the design of each experiment and are indicated in figure legends. P<0.05 was considered to be statistically significant.
Study Approval
Care of all animals and procedures were conformed to the Guide for Care and Use of Laboratory Animals of the US National Institutes of Health and were approved by the Animal Subjects Committee of Baylor College of Medicine.
Results
Deletion of ERα From SIM1 Neurons Blunts Estrogenic Actions to Prevent Stress-Induced Pressor Responses
We have generated an SIM1-ERα-KO (Esr1 f/f /SIM1-Cre) mouse line, in which ERα (encoded by the Esr1 gene) is selectively deleted in single-minded 1 (SIM1) neurons. 26 As we reported previously, 26 SIM1-ERα-KO mice have ERα deleted primarily in the MeA ( Figure 1A) , with modest deletion in the medial preoptic area ( Figure 1B ) and the paraventricular nucleus (PVN) of the hypothalamus ( Figure 1C) . Here, we used female SIM1-ERα-KO mice and their control (Esr1 f/f ) littermates to examine the role of ERα in SIM1 neurons in the regulation of BP during stress. To this end, we measured BP and HR in conscious control and SIM1-ERα-KO female mice that received either OVX+V or OVX+E treatment, at the unstressed condition (baseline) followed by a 1-hour restraint that caused stress. We found that in OVX+V control mice, the restraint stress provoked strong and sustained increases in MAP compared with the baseline (Figure 2A and 2C) . Importantly, these stress-induced pressor responses were significantly blunted in OVX+E control females (Figure 2A and 2C) . These findings indicate that 17β-estradiol supplement in female mice prevents pressor responses induced by stress. We then tested the stress-induced pressor effects in female SIM1-ERα-KO mice. Interestingly, regardless whether SIM1-ERα-KO mice were treated with OVX+V or OVX+E, the restraint stress provoked robust increases in MAP, responses that were comparable with those seen in OVX+V control mice ( Figure 2B and 2C) . Notably, the levels of HR were significantly elevated by the restraint stress at multiple time points in OVX+V control mice, OVX+V or OVX+E SIM1-ERα-KO mice, but not in OVX+E control mice ( Figure 2D and 2E) ; however, the averaged HR at the baseline and during the 60-minute stress period were not significantly different presumably because of big variations among each mouse ( Figure 2F ). Changes in systolic arterial pressure and in diastolic arterial pressure were similar as MAP ( Figure S2A-S2F ). Terminal analyses revealed that OVX+V mice displayed expected uterine atrophy, which confirmed successful 17β-estradiol depletion, whereas OVX+E mice showed heavier uterus than OVX+V mice, indicating sufficient 17β-estradiol supplement ( Figure S2G ). Together, these results indicate that ERα expressed by SIM1 neurons is required to mediate estrogenic actions to prevent stress-induced pressor responses in female mice.
Deletion of ERα Selectively in the MeA Blunts Estrogenic Actions to Prevent Stress-Induced Pressor Responses
It is worth noting that in SIM1-ERα-KO mice, ERα was deleted primarily in the MeA, with modest ERα deletions in the medial preoptic area and the PVN. Therefore, BP phenotypes observed in SIM1-ERα-KO mice may result not only from loss of ERα in the MeA but also to some degree from loss of ERα in the medial preoptic area/PVN. To further confirm the physiological functions of ERα in MeA neurons, we used the stereotaxic AAV-Cre-GFP injections to the MeA (bilaterally) of female Esr1 f/f mice to selectively delete ERα in the MeA during the adulthood (MeA-ERα-KO mice); female Esr1 f/f mice receiving AAV-GFP stereotaxic injections into the MeA were used as controls (see Figure 3A for validation). Both MeA-ERα-KO and control mice were treated with OVX+E, and we assessed stress-induced pressor responses in these mice. In OVX+E control mice, the restraint stress failed to induce elevations in MAP Figure 3B and 3C) . However, in MeA-ERα-KO mice treated with OVX+E, the restraint stress evoked strong and sustained pressor responses ( Figure 3B and 3C) . Notably, the restraint stress did not alter HR of OVX+E control females, whereas in OVX+E MeA-ERα-KO mice, HR was significantly increased ( Figure 3D and 3E) . Changes in systolic arterial pressure and diastolic arterial pressure were similar as MAP ( Figure S3 ). Thus, these results are consistent with our observations from SIM1-ERα-KO mice, and further pinpoint ERα in the MeA as a critical site where 17β-estradiol acts to prevent stressinduced pressor responses in female mice.
17β-Estradiol Potentiates Stress-Induced Corticosterone
To explore how 17β-estradiol regulates BP during stress, we first measured the stress hormone, corticosterone. As expected, in OVX+V mice, stress increased plasma corticosterone levels compared with the baseline. However, this stress-induced corticosterone response was further potentiated, instead of inhibited, in OVX+E mice ( Figure S4 ). Indeed, similar phenomenon has been reported in female rats treated with 17β-estradiol. 33 Thus, it is not likely that 17β-estradiol prevents stress-induced pressor responses via its actions on corticosterone levels.
Loss of ERα Increases Excitability of MeA SIM1 Neurons
It has been shown that 17β-estradiol supplement attenuates stress-induced c-fos immunoreactivity in the MeA, 34 indicating that estrogen prevents neural activation of MeA neurons during stress. However, mechanisms underlying these estrogenic actions were not known. Here, we tested if ERα expressed by MeA neurons is involved in the excitability of these neurons. To this end, we used the whole-cell patch-clamp electrophysiology to record firing activities of identified MeA SIM1 neurons from female control versus SIM1-ERα-KO mice ( Figure 4A ). We found that MeA SIM1 neurons in SIM1-ERα-KO mice showed significantly increased firing frequency compared with those in control mice, whereas the resting membrane potential was comparable between the 2 groups ( Figure 4B-4D) . We further analyzed the mEPSC in these neurons and found that both the amplitude and the frequency of mEPSC in MeA SIM1 neurons from SIM1-ERα-KO mice were significantly increased compared with those from control mice ( Figure 4E-4G) . In contrast, the amplitude and frequency of miniature inhibitory postsynaptic currents were not significantly different between the 2 groups ( Figure 4H-4J) . Furthermore, we found that mRNA levels of the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor subunits (GluA1 and GluA2) and the N-methyl-d-aspartate (NMDA) receptor subunit (GluN1) were significantly elevated in the amygdala of female SIM1-ERα-KO mice compared with control littermates, whereas expression of other ERs (including ERβ and G-protein-coupled receptor 30) was comparable between the 2 groups ( Figure 4K ). We further confirmed that the protein levels of GluN1 in the amygdala of female SIM1-ERα-KO mice were significantly higher than those from control mice ( Figure 4L and 4M) . Compared with the ionotropic AMPA and NMDA glutamate receptors, mRNAs of metabotropic glutamate receptors (mGluR1-mGluR8) were . Data are presented as mean±SEM; n=6 to 9 per group. *P<0.05 between OVX+V and OVX+E in 2-way ANOVA followed by post hoc Sidak tests. C, Averaged MAP at the baseline or at the restrained condition in OVX+V or OVX+E-treated control and SIM1-ERα-KO mice. Data are presented as mean±SEM; n=6 to 9 per group. *P<0.05 or **P<0.01 between baseline and stress condition within the same mice; #P<0.05 between OVX+V and OVX+E within the same genotype in 2-way ANOVA followed by post hoc Sidak tests. D and E, Temporal changes in heart rate in OVX+V or OVX+E-treated control (D) and SIM1-ERα-KO (E) mice at the baseline (−20 to 0 minutes) and the restrained condition (0-60 minutes). Data are presented as mean±SEM; n=6 to 9 per group. #P<0.05 vs the baseline within the same group of mice in t tests. F, Averaged heart rate at the baseline or at the restrained condition in OVX+V or OVX+E-treated control and SIM1-ERα-KO mice. Data are presented as mean±SEM; n=6 to 9 per group.
by guest on August 30, 2017 http://hyper.ahajournals.org/ Downloaded from less abundant in the amygdala of control mice and were not significantly changed in the amygdala of SIM1-ERα-KO mice ( Figure 4K ). In summary, these results indicate that loss of ERα in MeA SIM1 neurons leads to increased expression of ionotropic glutamate receptors, which is associated with increased excitability of these neurons.
Selective Activation of MeA SIM1 Neurons Increases BP
It has been shown that lesions of the MeA reduce BP in mice 35 and rats, 36 which suggest that MeA neurons are vasopressors. Here, we used DREADD approach 20 to selectively activate MeA SIM1 neurons in free-moving mice ( Figure 5A ). To prove the concept that the designers' drug, CNO, does activate these hM3Dq-mCherry-expresing SIM1 neurons, we used the wholecell patch-clamp electrophysiology to record effects of CNO on the firing activities of mCherry-labeled neurons in brain slices prepared from AAV-hM3Dq-mCherry-infected SIM1-Cre mice ( Figure 5B ). We showed that CNO (10 μmol/L, bath 6 minutes) increased the firing frequency of all recorded mCherry-labeled MeA SIM1 neurons and caused depolarization ( Figure 5C-5E) . Importantly, we showed in vivo that CNO injections (3 mg/kg, IP) significantly increased MAP and HR compared with saline treatment in the same mice ( Figure 5F and 5G). Similar changes in systolic arterial pressure and diastolic arterial pressure were observed (data not shown). Together, these data demonstrate that selective activation of MeA SIM1 neurons provokes pressor responses in mice.
Discussion
The MeA has been implicated as a key brain structure that links stress and development of hypertension. First, various physical and psychological stressors (eg, noise, restraint, and forced swim) activate neurons in the MeA. [37] [38] [39] Interestingly, increased MeA neural activities are correlated with stress-induced pressor responses in animals 13, 14 and in humans. 16 Supporting a physiological role of MeA neurons in the regulation of BP, lesions of the MeA lower BP in BPH/2J genetically hypertensive mice 35 and in spontaneously hypertensive rats. 36 Here, we provided the direct functional evidence that the DREADD-mediated activation of a subset of MeA neurons (SIM1 neurons) results in increases in BP and HR. Collectively, these results indicate that elevated neural activities in the MeA mediate stress-induced pressor responses. Notably, activation of MeA neurons has been reported to trigger multiple behaviors, including grooming, 40 aggression, 40, 41 social recognition, and anxiety. 42 Thus, we suggest that the increased BP evoked by MeA neural activation could represent an important component of the complex adaptive behaviors in response to stressful challenges.
In various hypertension animal models, OVX exacerbates the course of hypertension, whereas 17β-estradiol supplement prevents hypertension. [43] [44] [45] [46] [47] [48] [49] In particular, 17β-estradiol supplement prevents pressor responses induced by restraint stress in rodents 50, 51 and in postmenopausal women. 8 However, the mechanisms for this protective effect remain unknown. Here, we demonstrated that genetic deletion of ERα selectively in SIM1 neurons blunted the effects of . Data are presented as mean±SEM; n=5 per group. *P<0.05 in 2-way ANOVA analysis followed by post hoc Sidak tests. C, Averaged MAP at the baseline or at the restrained condition in OVX+E-treated control and MeA-ERα-KO mice. Data are presented as mean±SEM; n=5 per group. **P<0.01 between baseline and stress condition within the same mice; #P<0.05 between control and MeA-ERα-KO mice in 2-way ANOVA analysis followed by post hoc Sidak tests. D and E, Temporal changes in heart rate in OVX+E-treated control and MeA-ERα-KO mice at the baseline (−20 to 0 minutes) and the restrained condition (0-60 minutes). Data are presented as mean±SEM; n=5 per group. *P<0.05 in 2-way ANOVA followed by post hoc Sidak tests. F, Averaged heart rate at the baseline or at the restrained condition in OVX+E-treated control and MeA-ERα-KO mice. Data are presented as mean±SEM; n=5/group. *P<0.05 between baseline and stress condition within the same mice in 2-way ANOVA followed by post hoc Sidak tests. 3V indicates third ventricle; ARH, arcuate nucleus of the hypothalamus; MeA, medial amygdala; opt, optic tract; and VMH, ventromedial hypothalamic nucleus.
by guest on August 30, 2017 http://hyper.ahajournals.org/ Downloaded from 17β-estradiol to prevent stress-induced pressor responses in female mice. Given that most of SIM1-Cre-mediated ERα deletion is restricted in the MeA (with minor deletions in the medial preoptic area and PVN), we suggest that this phenotype results primarily from loss of ERα in the MeA. Consistently, Xue et al 52 has reported that selective knockdown of ERα in the PVN does not affect BP in rats. The specific role of MeA ERα was further confirmed in mice lacking ERα only in the MeA (through the stereotaxic AAVCre-GFP approach). Thus, we provided compelling evidence to highlight ERα expressed by MeA neurons as the key mediator for the antihypertensive effects of 17β-estradiol during stress. Of course, it is worth noting that other ERs, including ERβ 52, 53 and G-protein-coupled receptor 30, 54 are both implicated in the regulation of BP. Both these receptors are highly expressed in the MeA. 19, 55 Functions of ERβ and G-protein-coupled receptor 30 in the regulation of stressinduced pressor responses warrant further investigations. The mechanisms by which estrogen-ERα signals prevent stress-induced pressor responses at least partly involve an inhibition of MeA neurons during stress. Supporting this notion, it has been reported that chronic 17β-estradiol supplement attenuates MeA neural activation (c-fos immunoreactivity) evoked by the restraint stress. 34 Consistently, we found that MeA SIM1 neurons lacking ERα showed increased firing frequency associated with increased mEPSC, indicating that ERα-mediated signals in these neurons inhibit their firing activity. Notably, we recently reported that a selective ERα agonist, propyl pyrazole triol, rapidly (in the time scale of mini-seconds) activates MeA neurons in an ERα-dependent manner. 26 This propyl pyrazole triol-induced rapid activation seems to be in contrast to the activation of MeA neurons caused by chronic loss of ERα. Similar discrepancy also exists in animals receiving acute versus chronic 17β-estradiol treatment. Although acute injections of 17β-estradiol rapidly induce c-fos immunoreactivity in the MeA, 56 chronic 17β-estradiol supplement prevents stress-induced c-fos immunoreactivity in the same brain region. 34 We suggest that these opposite rapid versus chronic effects are mediated by segregated rapid signals versus genomic effects of ERα. On one hand, estrogen can act on ERα to rapidly activate neural activity, phenomena that have been widely observed in multiple neural populations. 27, 57, 58 On the other hand, in a more chronic setting, ERα functions as a classic nuclear receptor to regulate expression of target genes. Indeed, it has been reported that chronic 17β-estradiol treatment in ovariectomized rodents decreases expression of ionotropic glutamate receptors in the amygdala and hypothalamus. 59, 60 Consistently, we showed that deletion of ERα increased levels of ionotropic glutamate receptors in the MeA, which may have contributed to the increased mEPSC and firing frequency. Collectively, we suggest that estrogen inhibits expression of ionotropic glutamate receptors in amygdalar neurons, presumably through genomic ERα actions as a nuclear receptor. Thus, low levels of glutamate receptors decrease the excitability of these MeA neurons and prevent them from stress-induced activation.
Notably, changes in HR were largely correlated with changes in BP in most cases. For example, we showed that DREADDmediated stimulation of MeA neurons increased BP and HR. Similarly, restraint stress caused increases in both BP and HR.
These results are consistent with several previous reports in rats 50 or in mice. 61 Importantly, 17β-estradiol treatment in control mice prevented stress-induced increases in both BP and HR, whereas these effects were both blunted in mice lacking ERα in MeA neurons. This pattern suggests that the regulations on BP are at least partly through modulations on cardiac functions. However, we could not fully exclude the possibility that MeA neurons may also regulate BP via actions on the vascular tone.
How ERα-expressing MeA neurons regulate BP and HR during stress is unknown. Stress is well known to activate the hypothalamus-pituitary-adrenal axis and leads to elevated corticosterone levels in the circulation, which may partly contribute to the stress-induced pressor responses. However, it has been shown that 17β-estradiol supplement potentiates, instead of inhibits, stress-induced corticosterone release in female rats. 33 Similar potentiated corticosterone levels were observed in our OVX+E mice compared with OVX+V mice under the stressed condition, although the corticosterone level at a single time point during the stress may not fully reflect responses of the hypothalamus-pituitary-adrenal axis. Given the antihypertensive effects of ERα-expressing MeA neurons during stress, we suggest that estrogenic actions on the hypothalamus-pituitaryadrenal responses and on BP responses to stress are likely mediated by distinct neural circuits. The neural circuits by which MeA neurons regulate BP balance remain to be elucidated. 
Perspectives
In summary, our studies provide evidence that MeA neurons are vasopressors, and activation of these MeA neurons mediates the elevations in BP during restraint stress. Furthermore, we demonstrate that estrogen acts on ERα expressed by MeA neurons to prevent stress-induced pressor responses in female mice. These antihypertensive effects of MeA ERα seem to be mediated through transcription control of ionotropic glutamate receptors in MeA neurons. Thus, we identified MeA ERα as a potential therapeutic target for hypertension, especially in postmenopausal women.
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